M
Mazen Animal Health
Focused on developing, delivering, and commercializing novel biological vaccines and therapeutics
About Mazen Animal Health
Mazen Animal Health operates in the animal health market, leveraging biotechnology to develop plant-based vaccines that are administered orally via animal feed. The company's innovative approach replaces traditional injectable vaccines, aiming to lower production costs, improve worker safety, enhance animal welfare, and strengthen biosecurity. Mazen's core clients include livestock producers and animal health professionals who benefit from more efficient and safer vaccination methods. The business model focuses on the production and sale of these plant-based vaccines, generating revenue through direct sales and partnerships within the animal health industry. By utilizing molecular farming technologies, Mazen transforms plants into natural production factories for recombinant proteins and other high-value molecules, positioning itself at the forefront of this emerging field. The company is committed to continuous improvement and long-term partnerships within the animal health community, driven by a diverse team with expertise in biotechnology, production, manufacturing, and business acumen.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Ames, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 37.9/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Vaccines, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2022 | $11M | $44M | Next Level Ventures · ISA Ventures · Summit Ag · Addison Biological Laboratory | ↗ |
| SEED✓Equity / VC | May 2021 | $2M | $8M | ISA Ventures · Kent Corporation · Summit Ag · Next Level Ventures | — |
Growth signals
Latest recorded traffic for Mazen Animal Health is 710 monthly website visits, down 35.5% over the last three months. Mazen Animal Health's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
Innovation in Motion
Next Level Ventures
ISA Ventures
Kent Corporation
Summit Ag
Ag Ventures Alliance
Ag Startup Engine
Series A6 investors entered at this stage
Fall Line Capital- ALAddison Biological Laboratory
- 1I1330 Investments
AgFunder- CVCentral Coast Ventures (Formerly SLO Seed Ventures)
Cal Poly Ventures
Other known investors5 additional known investors
California Polytechnic State University
Iowa G2M Accelerator
Missouri Technology Corporation
Twelve19 Ventures
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mazen Animal Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mazen Animal Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







